Filtered By:
Drug: Pradaxa
Countries: New Zealand Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 19 results found since Jan 2013.
Stroke thrombolysis in a patient on dabigatran in the extended time window
N Z Med J. 2022 Jan 20;136(1568):105-108.NO ABSTRACTPMID:36657080
Source: New Zealand Medical Journal - January 19, 2023 Category: General Medicine Authors: Stewart Shiu Bobae Lee Karim M Mahawish Source Type: research
The changing use of anticoagulants in New Zealand
CONCLUSIONS: The introduction of the DOACs was expected to reduce the use of warfarin. However, the rapid rise in DOAC use was not predicted. The increase is most likely in patients with atrial fibrillation with the positive benefit of reducing the incidence of embolic stroke. However, having a high proportion of the elderly population (15% of people over 75-years) on anticoagulants has implications for the health sector, making hospital admissions and surgery more complex.PMID:35728215
Source: New Zealand Medical Journal - June 21, 2022 Category: General Medicine Authors: Paul Harper Alison Chang Matt Stephens Source Type: research
